 Principal Financial Group Inc. increased its holdings in ImmunoGen, Inc. NASDAQ:IMGN by 334.4 in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission SEC. The institutional investor owned 180,299 shares of the biotechnology companys stock after buying an additional 138,791 shares during the quarter. Principal Financial Group Inc. ... 